Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progression.

Abstract:

:The genetically heterogeneous triple-negative breast cancer (TNBC) continues to be an intractable disease, due to lack of effective targeted therapies. Gene amplification is a major event in tumorigenesis. Genes with amplification-dependent expression are being explored as therapeutic targets for cancer treatment. In this study, we have applied Analytical Multi-scale Identification of Recurring Events analysis and transcript quantification in the TNBC genome across 222 TNBC tumors and identified 138 candidate genes with positive correlation in copy number gain (CNG) and gene expression. siRNA-based loss-of-function screen of the candidate genes has validated EGFR, MYC, ASAP1, IRF2BP2, and CCT5 genes as drivers promoting proliferation in different TNBC cells. MYC, ASAP1, IRF2BP2, and CCT5 display frequent CNG and concurrent expression over 2173 breast cancer tumors (cBioPortal dataset). More frequently are MYC and ASAP1 amplified in TNBC tumors (>30%, n = 320). In particular, high expression of ASAP1, the ADP-ribosylation factor GTPase-activating protein, is significantly related to poor metastatic relapse-free survival of TNBC patients (n = 257, bc-GenExMiner). Furthermore, we have revealed that silencing of ASAP1 modulates numerous cytokine and apoptosis signaling components, such as IL1B, TRAF1, AIFM2, and MAP3K11 that are clinically relevant to survival outcomes of TNBC patients. ASAP1 has been reported to promote invasion and metastasis in various cancer cells. Our findings that ASAP1 is an amplification-dependent TNBC driver gene promoting TNBC cell proliferation, functioning upstream apoptosis components, and correlating to clinical outcomes of TNBC patients, support ASAP1 as a potential actionable target for TNBC treatment.

journal_name

Oncogene

journal_title

Oncogene

authors

He J,McLaughlin RP,van der Beek L,Canisius S,Wessels L,Smid M,Martens JWM,Foekens JA,Zhang Y,van de Water B

doi

10.1038/s41388-020-1279-3

subject

Has Abstract

pub_date

2020-05-01 00:00:00

pages

4118-4131

issue

20

eissn

0950-9232

issn

1476-5594

pii

10.1038/s41388-020-1279-3

journal_volume

39

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Wn mutation of c-kit receptor affects its post-translational processing and extracellular expression.

    abstract::The W locus of mice encodes the c-kit receptor tyrosine kinase. Recently, we characterized a novel mutant allele, Wn, and demonstrated that the c-kit protein synthesized in Wn/Wn cultured mast cells (CMC) was reduced in size and not expressed on their surface (Tsujimura et al., 1993). In this study, we further examine...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Koshimizu U,Tsujimura T,Isozaki K,Nomura S,Furitsu T,Kanakura Y,Kitamura Y,Nishimune Y

    更新日期:1994-01-01 00:00:00

  • Bruton's tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma.

    abstract::Aberrant activation of anaplastic lymphoma kinase (ALK) can cause sporadic and familial neuroblastoma. Using a proteomics approach, we identified Bruton's tyrosine kinase (BTK) as a novel ALK interaction partner, and the physical interaction was confirmed by co-immunoprecipitation. BTK is expressed in neuroblastoma ce...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0397-7

    authors: Li T,Deng Y,Shi Y,Tian R,Chen Y,Zou L,Kazi JU,Rönnstrand L,Feng B,Chan SO,Chan WY,Sun J,Zhao H

    更新日期:2018-11-01 00:00:00

  • Characterization of the cell membrane-associated products of the Neuregulin 4 gene.

    abstract::The NRG4 gene is a member of a family of four genes that encode a class of epidermal growth factors. This gene has been reported to express a protein designated here as NRG4A1. We describe here a novel splice variant of the NRG4 gene, NRG4A2, which encodes a C-terminal region containing a predicted type I PDZ-binding ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210689

    authors: Hayes NV,Newsam RJ,Baines AJ,Gullick WJ

    更新日期:2008-01-24 00:00:00

  • Raf-1 kinase and ERK2 uncoupled from mitogenic signals in rat fibroblasts.

    abstract::The MAP kinase pathway impinging on ERK2 has been shown to be integrally associated with mitogenic signalling in many cell types. Previously, we and others have demonstrated that oncogenic forms of Raf-1 kinase, when expressed in fibroblasts, lead to the constitutive activation of ERK2, the de-regulation of c-fos expr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kortenjann M,Shaw PE

    更新日期:1995-11-16 00:00:00

  • rsc: a novel oncogene with structural and functional homology with the gene family of exchange factors for Ral.

    abstract::A novel oncogene, rsc (rabbit squamous cell carcinoma), has been identified from a DMBA-induced rabbit squamous cell carcinoma using gene transfer and the nude mouse tumorigenesis assay. A full-length cDNA has been isolated and sequenced. rsc has potent tumorigenic activity in nude mice (latency <4 weeks), but does no...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1200950

    authors: D'Adamo DR,Novick S,Kahn JM,Leonardi P,Pellicer A

    更新日期:1997-03-20 00:00:00

  • Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients.

    abstract::Imatinib-acquired resistance related to the presence of secondary point mutations has become a frequent event in gastrointestinal stromal tumors. Here, transient transfection experiments with plasmids carrying two different KIT-acquired point mutations were performed along with immunoprecipitation of total protein ext...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209639

    authors: Tamborini E,Pricl S,Negri T,Lagonigro MS,Miselli F,Greco A,Gronchi A,Casali PG,Ferrone M,Fermeglia M,Carbone A,Pierotti MA,Pilotti S

    更新日期:2006-10-05 00:00:00

  • The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense.

    abstract::Only humans and higher primates have high uric acid blood levels. Although high uric acid causes gout, it has been linked with human longevity because of its hypothetical antioxidant function. Recent studies reveal that p53 has significant roles in cellular metabolism. One example of this is an antioxidant function th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.119

    authors: Itahana Y,Han R,Barbier S,Lei Z,Rozen S,Itahana K

    更新日期:2015-04-02 00:00:00

  • Apoptosis and melanoma chemoresistance.

    abstract::Melanoma is the most aggressive form of skin cancer and is notoriously resistant to all current modalities of cancer therapy. A large set of genetic, functional and biochemical studies suggest that melanoma cells become 'bullet proof' against a variety of chemotherapeutic drugs by exploiting their intrinsic resistance...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1206454

    authors: Soengas MS,Lowe SW

    更新日期:2003-05-19 00:00:00

  • SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment.

    abstract::L-ascorbate (L-ascorbic acid, vitamin C) clearly has an inhibitory effect on cancer cells. However, the mechanism underlying differential sensitivity of cancer cells from same tissue to L-ascorbate is yet to be clarified. Here, we demonstrate that L-ascorbate has a selective killing effect, which is influenced by sodi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.176

    authors: Hong SW,Lee SH,Moon JH,Hwang JJ,Kim DE,Ko E,Kim HS,Cho IJ,Kang JS,Kim DJ,Kim JE,Shin JS,Jung DJ,Jeong YJ,Cho BJ,Kim TW,Lee JS,Kang JS,Hwang YI,Noh DY,Jin DH,Lee WJ

    更新日期:2013-03-21 00:00:00

  • MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers.

    abstract::Homeobox genes encode transcription factors that are essential for normal development and are often dysregulated in cancers. The molecular mechanisms that cause their misregulation in cancers are largely unknown. In this study, we investigate the mechanism by which the Six1 homeobox protein, which has a crucial role d...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.233

    authors: Imam JS,Buddavarapu K,Lee-Chang JS,Ganapathy S,Camosy C,Chen Y,Rao MK

    更新日期:2010-09-02 00:00:00

  • Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.

    abstract::The microtubule-targeting antineoplastic agent, paclitaxel, is highly efficacious against a wide spectrum of human cancers. However, dose-limiting toxicity and development of drug resistance limit its clinical application. Development of novel strategies that overcome chemoresistance and sensitize cancer cells to pacl...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.23

    authors: Sreekanth CN,Bava SV,Sreekumar E,Anto RJ

    更新日期:2011-07-14 00:00:00

  • Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth.

    abstract::AP-1 transcription factors play a critical role in signal transduction pathways in many cells. We have investigated the role of AP-1 in controlling proliferative signals in breast cells, and have previously shown that AP-1 complexes are activated by peptide and steroid growth factors in both normal and malignant breas...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205883

    authors: Liu Y,Ludes-Meyers J,Zhang Y,Munoz-Medellin D,Kim HT,Lu C,Ge G,Schiff R,Hilsenbeck SG,Osborne CK,Brown PH

    更新日期:2002-10-31 00:00:00

  • Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors.

    abstract::SHP-2 protein tyrosine phosphatase plays an important role in activation of the RAS-dependent signaling. Gain-of-function mutations in the PTPN11 gene, which encodes SHP-2, have been found in the leukemia-prone developmental disorder Noonan syndrome as well as sporadic childhood leukemias, indicating that SHP-2 is a b...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1211019

    authors: Miyamoto D,Miyamoto M,Takahashi A,Yomogita Y,Higashi H,Kondo S,Hatakeyama M

    更新日期:2008-06-05 00:00:00

  • Cytokine receptors and hematopoietic differentiation.

    abstract::Colony-stimulating factors and other cytokines signal via their cognate receptors to regulate hematopoiesis. In many developmental systems, inductive signalling determines cell fate and, by analogy with this, it has been postulated that cytokines, signalling via their cognate receptors, may play an instructive role in...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1210756

    authors: Robb L

    更新日期:2007-10-15 00:00:00

  • The c-Rel transcription factor can both induce and inhibit apoptosis in the same cells via the upregulation of MnSOD.

    abstract::Rel/NF-kappaB transcription factors are involved in several physiological processes, including the regulation of apoptosis. These factors were shown to exhibit pro- or anti-apoptotic activities in different cellular models, but at present, the mechanisms underlying these opposite effects are poorly understood. In this...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205536

    authors: Bernard D,Monte D,Vandenbunder B,Abbadie C

    更新日期:2002-06-27 00:00:00

  • Expression of Brca1 and splice variant Brca1delta11 RNA levels in mouse mammary gland during normal development and tumorigenesis.

    abstract::Expression of Brca1 in mouse mammary cancer has yet to be analysed. We use a progressive model of neoplasia based on several mouse epithelial cell lines that represent distinct steps toward the fully tumorigenic state. Using RNase protection analysis because acceptable anti-Brca1 antibodies are not available we invest...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203905

    authors: Mixon M,Kittrell F,Medina D

    更新日期:2000-11-02 00:00:00

  • Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.

    abstract::The discovery of constitutive nuclear factor-κB (NF-κB) activation in Hodgkin's lymphoma tumor cells almost two decades ago was one of the first reports that directly connected deregulated NF-κB signaling to human cancer. Subsequent studies demonstrated that enhanced NF-κB signaling is a common hallmark of many lympho...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2013.565

    authors: Nagel D,Vincendeau M,Eitelhuber AC,Krappmann D

    更新日期:2014-12-11 00:00:00

  • SUMOylation inhibits FOXM1 activity and delays mitotic transition.

    abstract::The forkhead box transcription factor FOXM1 is an essential effector of G2/M-phase transition, mitosis and the DNA damage response. As such, it is frequently deregulated during tumorigenesis. Here we report that FOXM1 is dynamically modified by SUMO1 but not by SUMO2/3 at multiple sites. We show that FOXM1 SUMOylation...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.546

    authors: Myatt SS,Kongsema M,Man CW,Kelly DJ,Gomes AR,Khongkow P,Karunarathna U,Zona S,Langer JK,Dunsby CW,Coombes RC,French PM,Brosens JJ,Lam EW

    更新日期:2014-08-21 00:00:00

  • Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression.

    abstract::The molecular basis for the resistance of tumor cells to cell-mediated cytotoxicity remains poorly understood and thus poses a major challenge for cancer immunotherapy. The present study was designed to determine whether the WNT1-inducible signaling pathway protein 2 (WISP2, also referred to as CCN5), a key regulator ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.151

    authors: Akalay I,Tan TZ,Kumar P,Janji B,Mami-Chouaib F,Charpy C,Vielh P,Larsen AK,Thiery JP,Sabbah M,Chouaib S

    更新日期:2015-04-23 00:00:00

  • TIPUH1 encodes a novel KRAB zinc-finger protein highly expressed in human hepatocellular carcinomas.

    abstract::To achieve a better understanding of mechanisms that underlie hepatocarcinogenesis and to identify novel target molecules for diagnosis and therapy of hepatocellular carcinoma (HCC), we previously analysed gene-expression profiles of 20 HCC tissues on a cDNA microarray. Among the genes upregulated in the tumor tissues...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209517

    authors: Silva FP,Hamamoto R,Furukawa Y,Nakamura Y

    更新日期:2006-08-17 00:00:00

  • Mysterious liaisons: the relationship between c-Myc and the cell cycle.

    abstract::A large body of physiological evidence shows that either upregulation or downregulation of intracellular c-Myc activity has profound consequences on cell cycle progression. Recent work suggests that c-Myc may stimulate the activity of cyclin E/cyclin-dependent kinase 2 (Cdk2) complexes and antagonize the action of the...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1202749

    authors: Obaya AJ,Mateyak MK,Sedivy JM

    更新日期:1999-05-13 00:00:00

  • Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex.

    abstract::Mammalian Mip/LIN-9 is a cell cycle regulatory protein that is negatively regulated by CDK4/cyclin D. It has been demonstrated that Mip/LIN-9 collaborates with B-Myb during S and G(2)/M in the induction of cyclins A and B, and CDK1. The ortholog of Mip/LIN-9 in Drosophila, Mip130, is part of a large multisubunit prote...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210562

    authors: Pilkinton M,Sandoval R,Colamonici OR

    更新日期:2007-11-29 00:00:00

  • Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer.

    abstract::ID4 gene is a member of the inhibitor of DNA-binding (ID) family, which inhibits DNA binding of basic helix-loop-helix transcription factors. Certain human primary breast cancers reportedly have low or no expression of ID4 protein, but its role in carcinogenesis and cancer progression is unknown. To determine its poss...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208538

    authors: Umetani N,Mori T,Koyanagi K,Shinozaki M,Kim J,Giuliano AE,Hoon DS

    更新日期:2005-07-07 00:00:00

  • And-1 is required for the stability of histone acetyltransferase Gcn5.

    abstract::Histone acetyltransferases (HATs) have a central role in the modification of chromatin as well as in the pathogenesis of a broad set of diseases including cancers. Gcn5 is the first identified transcription-related HAT that has been implicated in the regulation of diverse cellular functions. However, how Gcn5 proteins...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.261

    authors: Li Y,Jaramillo-Lambert AN,Yang Y,Williams R,Lee NH,Zhu W

    更新日期:2012-02-02 00:00:00

  • p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.

    abstract::Constitutive activation of the signal transducer and activator of transcription 3 (Stat3) and mutation of the p53 are both commonly detected in human prostate cancer cells. We sought to investigate whether there is functional regulation of Stat3 by wild-type (wt) p53. Our results demonstrate that expression of wt p53 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205426

    authors: Lin J,Tang H,Jin X,Jia G,Hsieh JT

    更新日期:2002-05-02 00:00:00

  • Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis.

    abstract::The NAD-dependent deacetylase sirtuin 1 (SIRT1), a member of the mammalian sirtuin family, plays a pivotal role in deacetylating histone and nonhistone proteins. Recently, it has been reported that SIRT1 is upregulated in various kinds of tumors and is associated with cell growth and metastasis. However, the factors a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-1298-0

    authors: Yu L,Dong L,Li H,Liu Z,Luo Z,Duan G,Dai X,Lin Z

    更新日期:2020-05-01 00:00:00

  • The p53 knowledgebase: an integrated information resource for p53 research.

    abstract::The p53 tumor suppressor protein plays a central role in maintaining genomic integrity by occupying a nodal point in the DNA damage control pathway. Here it integrates a wide variety of signals, responding in one of several ways, that is, cell cycle arrest, senescence or programmed cell death (apoptosis). Mutations in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209952

    authors: Lim YP,Lim TT,Chan YL,Song AC,Yeo BH,Vojtesek B,Coomber D,Rajagopal G,Lane D

    更新日期:2007-03-08 00:00:00

  • Regional localization of the human c-rel locus using translocation chromosome analysis.

    abstract::The human cellular homolog of v-rel, the transforming gene of reticuloendotheliosis virus, strain T, was previously localized to 2 cent-2p13 by a combination of somatic cell hybrid and in situ hybridization analyses. In this study, we use translocation chromosome analysis to refine c-rel's genetic assignment to 2p12-2...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Brownell E,Fell HP,Tucker PW,Geurts van Kessel AH,Hagemeijer A,Rice NR

    更新日期:1988-05-01 00:00:00

  • Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma.

    abstract::Tumor necrosis factor-related apoptosis-inducing ligand-receptor 1 (TRAIL-R1) and tumor necrosis factor-related apoptosis-inducing ligand-receptor 2 (TRAIL-R2) are cell-surface receptors involved in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell-death signaling. TRAIL-R1 and TRAIL-R2 gene...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204103

    authors: Lee SH,Shin MS,Kim HS,Lee HK,Park WS,Kim SY,Lee JH,Han SY,Park JY,Oh RR,Kang CS,Kim KM,Jang JJ,Nam SW,Lee JY,Yoo NJ

    更新日期:2001-01-18 00:00:00

  • Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells.

    abstract::Somatic alterations of fibroblast growth factor receptors (FGFRs) have been described in a wide range of malignancies. A number of anti-FGFR therapies are currently under investigation in clinical trials for subjects with FGFR gene amplifications, mutations and translocations. Here, we develop cell line models of acqu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.161

    authors: Wang J,Mikse O,Liao RG,Li Y,Tan L,Janne PA,Gray NS,Wong KK,Hammerman PS

    更新日期:2015-04-23 00:00:00